Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis

• Published in: Annals of hepatology Vol. 19; no. 5; pp. 466 - 471
• Main Authors: Islam, S.M. Touhidul, Won, Jeseong, Khan, Mushfiquddin, Chavin, Kenneth D., Singh, Inderjit
• Format: Journal Article
• Language: English
• Published: Mexico Elsevier España, S.L.U 01.09.2020; Elsevier
• Subjects: Gastroenterology and Hepatology; Nonalcoholic steatohepatitis; PPAR-α; TLR-4; PPAR-α; TLR-4; Nonalcoholic steatohepatitis
• ISSN: 1665-2681; 2659-5982
• DOI: 10.1016/j.aohep.2019.11.007

Nonalcoholic steatohepatitis (NASH) is a form of fatty liver disease where benign hepatic steatosis leads to chronic inflammation in the steatotic liver of a patient without any history of alcohol abuse. Mechanisms underlying the progression of hepatic steatosis to NASH have long been investigated. This review outlines the potential role of peroxisomal dysfunctions in exacerbating the disease in NASH. Loss of peroxisomes as well as impaired peroxisomal functions have been demonstrated to occur in inflammatory conditions including NASH. Because peroxisomes and mitochondria co-operatively perform many metabolic functions including O2 and lipid metabolisms, a compromised peroxisomal biogenesis and function can potentially contribute to defective lipid and reactive oxygen species metabolism which in turn can lead the progression of disease in NASH. Impaired peroxisomal biogenesis and function may be due to the decreased expression of peroxisomal proliferator-activated receptor-α (PPAR-α), the major transcription factor of peroxisomal biogenesis. Recent studies indicate that the reduced expression of PPAR-α in NASH is correlated with the activation of the toll-like receptor-4 pathway (TLR-4). Further investigations are required to establish the mechanistic connection between the TLR-4 pathway and PPAR-α-dependent impaired biogenesis/function of peroxisomes in NASH.